Grant: Discovery Grants Program - Individual
Queen's University
$38,000.00
Regulation of angiogenesis at the maternal-fetal interface
EF 2014-15
Résumé
Blastocyst implantation, placentation and successful pregnancy require coordinated vascular development/ remodeling and functional adaptations on both maternal-fetal sides of implantation sites. At implantation, a richly vascularized endometrium is critical for successful implantation. Shortly after implantation, growth of this vasculature is essential to facilitate nutrients and oxygen transport to the conceptus. Immune cells, in particular natural killer cells, dendritic cells and macrophages are recruited to the implantation sites where they have pivotal roles in angiogenesis and regulation of maternal-fetal cross talk but their recruitment signals are poorly understood. Alterations in angiogenesis and immune cell functions lead to fetal loss. We hypothesize that immune cells are recruited and positioned within the maternal-fetal interface by specific chemokine signals and their angiogenic properties are regulated by specific microRNAs. Using our previously established technical approach of Laser Capture Microdissection for studies in pig and mice, Aim1 will characterize chemokine recruitment signals from maternal and fetal sides (their suitable receptors/decoy receptors) for immune cells. Aim2 will characterize important angiogenic factors and cytokines regulating pregnancy success in immune cell-subsets. Aim3 will define specific MicroRNAs regulating angiogenesis and immune cell development. Using targeted locked nucleic acid probes in mice, specific microRNAs identified in aim#3 will be blocked and in-vivo effects during pregnancy will be evaluated in Aim4. Proposed study will be conducted at specific time points in pregnancy to capture endometrial enrichment of immune cells and initiation of angiogenesis (gestation day (gd) 15 and 20 in porcine pregnancy and gd8, 10, 12 in mice). These studies will provide novel insights into pathways of immune cell recruitment and their role in angiogenesis regulation and ultimately fetal survival in species with non-invasive epitheliochorial placenta (pig) and invasive hemochorial placenta (mice). Outcomes from this study will help to target immune cells and their products for reducing fetal loss in pigs. Proposed research will provide training for 2 graduate and 3 summer students.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
386700-2010
Name nom
Tayade, Chandrakant
Department département
Biomedical and Molecular Sciences
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
38000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
5
Nb partie
5
Application title
Regulation of angiogenesis at the maternal-fetal interface
Keyword
NSERC
Application summary
Blastocyst implantation, placentation and successful pregnancy require coordinated vascular development/ remodeling and functional adaptations on both maternal-fetal sides of implantation sites. At implantation, a richly vascularized endometrium is critical for successful implantation. Shortly after implantation, growth of this vasculature is essential to facilitate nutrients and oxygen transport to the conceptus. Immune cells, in particular natural killer cells, dendritic cells and macrophages are recruited to the implantation sites where they have pivotal roles in angiogenesis and regulation of maternal-fetal cross talk but their recruitment signals are poorly understood. Alterations in angiogenesis and immune cell functions lead to fetal loss. We hypothesize that immune cells are recruited and positioned within the maternal-fetal interface by specific chemokine signals and their angiogenic properties are regulated by specific microRNAs. Using our previously established technical approach of Laser Capture Microdissection for studies in pig and mice, Aim1 will characterize chemokine recruitment signals from maternal and fetal sides (their suitable receptors/decoy receptors) for immune cells. Aim2 will characterize important angiogenic factors and cytokines regulating pregnancy success in immune cell-subsets. Aim3 will define specific MicroRNAs regulating angiogenesis and immune cell development. Using targeted locked nucleic acid probes in mice, specific microRNAs identified in aim#3 will be blocked and in-vivo effects during pregnancy will be evaluated in Aim4. Proposed study will be conducted at specific time points in pregnancy to capture endometrial enrichment of immune cells and initiation of angiogenesis (gestation day (gd) 15 and 20 in porcine pregnancy and gd8, 10, 12 in mice). These studies will provide novel insights into pathways of immune cell recruitment and their role in angiogenesis regulation and ultimately fetal survival in species with non-invasive epitheliochorial placenta (pig) and invasive hemochorial placenta (mice). Outcomes from this study will help to target immune cells and their products for reducing fetal loss in pigs. Proposed research will provide training for 2 graduate and 3 summer students.